Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Sites

Precipio has appointed Douglas Sites to the newly created position of vice president of sales, where he will be responsible for leading sales of the firm's cancer diagnostic services to oncologists and hospitals. The company also said that it plans to triple the size of its sales force in 2018, focusing first on small to midsize oncology practices and hospitals. Sites has spent the last 20 years in life sciences and cancer diagnostics, including roles as director of sales at Plus Diagnostics and VP of sales at Asuragen. 

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.